← All trials
NCT07226843
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2026
- Primary completion
- Feb 28, 2027
- Completion date
- Dec 31, 2029
- First posted
- Nov 12, 2025
- Last posted
- Nov 24, 2025
- Enrollment
- 360
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.